227 related articles for article (PubMed ID: 34944954)
1. Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System.
Montesinos-Rongen M; Brunn A; Sanchez-Ruiz M; Küppers R; Siebert R; Deckert M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944954
[TBL] [Abstract][Full Text] [Related]
2. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
3. Pathology and new insights in central nervous system lymphomas.
Lebrun L; Allard-Demoustiez S; Salmon I
Curr Opin Oncol; 2023 Sep; 35(5):347-356. PubMed ID: 37439536
[TBL] [Abstract][Full Text] [Related]
4. The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.
Montesinos-Rongen M; Terrao M; May C; Marcus K; Blümcke I; Hellmich M; Küppers R; Brunn A; Deckert M
Haematologica; 2021 Mar; 106(3):708-717. PubMed ID: 32193251
[TBL] [Abstract][Full Text] [Related]
5. The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
Vater I; Montesinos-Rongen M; Schlesner M; Haake A; Purschke F; Sprute R; Mettenmeyer N; Nazzal I; Nagel I; Gutwein J; Richter J; Buchhalter I; Russell RB; Wiestler OD; Eils R; Deckert M; Siebert R
Leukemia; 2015 Mar; 29(3):677-85. PubMed ID: 25189415
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
[TBL] [Abstract][Full Text] [Related]
7. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
[TBL] [Abstract][Full Text] [Related]
8. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
9. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).
Gordon MS; Kanegai CM; Doerr JR; Wall R
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4126-31. PubMed ID: 12651942
[TBL] [Abstract][Full Text] [Related]
10. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
11. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
Gu X; Booth CJ; Liu Z; Strout MP
Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
[TBL] [Abstract][Full Text] [Related]
12. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
Pasqualucci L; Neumeister P; Goossens T; Nanjangud G; Chaganti RS; Küppers R; Dalla-Favera R
Nature; 2001 Jul; 412(6844):341-6. PubMed ID: 11460166
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
[TBL] [Abstract][Full Text] [Related]
14. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
Front Immunol; 2021; 12():683597. PubMed ID: 34335584
[TBL] [Abstract][Full Text] [Related]
15. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
[TBL] [Abstract][Full Text] [Related]
17. Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins.
Montesinos-Rongen M; Purschke FG; Brunn A; May C; Nordhoff E; Marcus K; Deckert M
J Immunol; 2015 Aug; 195(3):1312-9. PubMed ID: 26116512
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation and B cell receptor selection in normal and transformed human B cells.
Küppers R
Ann N Y Acad Sci; 2003 Apr; 987():173-9. PubMed ID: 12727637
[TBL] [Abstract][Full Text] [Related]
19. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
20. M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice.
Schenten D; Egert A; Pasparakis M; Rajewsky K
Blood; 2006 Jun; 107(12):4849-56. PubMed ID: 16493007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]